当前位置:首页 - 行情中心 - 荣昌生物(688331) - 财务分析

荣昌生物

(688331)

  

流通市值:157.39亿  总市值:546.57亿
流通股本:1.62亿   总股本:5.64亿

荣昌生物(688331)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润-5.51亿元,每股收益-1.01元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益232008.31万元,未分配利润-487257.18万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产597712.99万元,负债365704.68万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入1,719,833,029.781,097,953,438.31525,968,624.061,716,861,688.03
营业总成本2,268,418,316.441,547,735,633.21783,824,467.593,227,249,148.21
其他经营收益
营业利润-537,269,154.58-441,154,140.6-249,746,497.51-1,455,655,359.91
利润总额-550,700,575.38-449,568,663.07-254,144,470.06-1,468,360,802.55
净利润-550,700,575.38-449,568,663.07-254,144,470.06-1,468,360,802.55
每股收益
其他综合收益49,592,840.3230,010,415.811,992,969.57-30,878,101.93
综合收益总额-501,107,735.06-419,558,247.27-242,151,500.49-1,499,238,904.48
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计2,719,142,876.942,698,160,087.742,160,787,697.472,289,796,373.31
非流动资产:
非流动资产合计3,257,987,007.183,152,198,029.183,146,557,350.553,208,721,795.51
资产总计5,977,129,884.125,850,358,116.925,307,345,048.025,498,518,168.82
流动负债:
流动负债合计2,832,798,494.682,547,894,786.182,344,955,090.42,178,296,653.17
非流动负债:
非流动负债合计824,248,325.8944,972,759.651,190,964,862.551,334,020,894.71
负债合计3,657,046,820.483,492,867,545.833,535,919,952.953,512,317,547.88
所有者权益(或股东权益):
归属于母公司股东权益合计2,320,083,063.642,357,490,571.091,771,425,095.071,986,200,620.94
股东权益合计2,320,083,063.642,357,490,571.091,771,425,095.071,986,200,620.94
负债和股东权益合计5,977,129,884.125,850,358,116.925,307,345,048.025,498,518,168.82
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计2,255,935,870.871,077,583,670.92479,999,884.371,632,499,851.97
经营活动现金流出小计2,038,878,436.931,323,122,926.19668,315,017.452,746,803,365.17
经营活动产生的现金流量净额217,057,433.94-245,539,255.27-188,315,133.08-1,114,303,513.2
投资活动产生的现金流量:
投资活动现金流入小计1,062,794,914.72261,654,258.4159,851,0251,023,796,795.04
投资活动现金流出小计1,342,340,631.06380,704,078.26186,638,909.831,272,031,866.7
投资活动产生的现金流量净额-279,545,716.34-119,049,819.86-26,787,884.83-248,235,071.66
筹资活动产生的现金流量:
筹资活动现金流入小计2,117,271,291.071,974,875,468.43530,696,523.81,805,605,239.32
筹资活动现金流出小计1,746,302,543.741,094,539,402.98353,972,558.77412,636,435.24
筹资活动产生的现金流量净额370,968,747.33880,336,065.45176,723,965.031,392,968,804.08
汇率变动对现金及现金等价物的影响-620,373.83-4,276,762.99-2,367,997.432,547,892.84
现金及现金等价物净增加额307,860,091.1511,470,227.33-40,747,050.3132,978,112.06
期末现金及现金等价物余额1,067,390,134.521,271,000,270.75718,782,993.11759,530,043.42
补充资料:
现金及现金等价物的净增加额-511,470,227.33-32,978,112.06
最新报告期:2025-12-01
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
中信证券陈竹-0.46-0.410.302025-12-01
东海证券杜永宏-1.55-0.580.162025-11-03
华安证券谭国超-1.35-0.860.122025-10-31
华泰证券代雯,李航,袁中平-0.600.010.982025-10-31
华泰证券代雯,李航,袁中平-0.610.000.952025-10-19
TOP↑